Scientists have developed a cheap portable camera that can photograph the retina without administering the dilating pupillary irritating drops. The camera works by first emitting infrared light, iris - the muscle that controls the opening of the pupil - does not react to.
The HIV and AIDS (Prevention and Control) Bill, 2014, which aims to ensure the equal rights of people living with HIV in medical treatment, education and employment, was adopted by Discrimination on the part of the state or any other person, while providing for penal provisions for any prejudice against a person with HIV / AIDS and for breach of confidentiality.
However, during the debate on the measure, many members suggested that part of the bill be amended to delete the phrase "to the extent possible" to provide medical treatment to the Center and States to persons infected with HIV and AIDS Defying on the purpose of the move.
However, during the debate on the measure, many members suggested that part of the bill be amended to delete the phrase "to the extent possible" to provide medical treatment to the Center and States to persons infected with HIV and AIDS Defying on the purpose of the move.
The bill makes it incumbent on central and state governments to provide for anti-retroviral therapy (ART) and management of opportunistic infections (infections that take advantage of weakness in the immune system and occur frequently). The protection provided by the bill extends to the areas of employment, health services, educational services, public facilities, property rights, the public service and insurance.
The bill, proposed by the Minister of Health, J P Nadda, was adopted in the Upper House by a vote of votes. Although the bill was presented to Parliament by the UPA government, amendments to the HIV and AIDS (Prevention and Control) Bill, 2014, were revived by the Modi government last July .
For instance, the bill now makes anti-retroviral treatment a legal right for all HIV/AIDS patients. Since then, the Ministry of Health has made several amendments to the original bill to address several concerns raised by the HIV community as well as state governments.
It has also adopted "test and treat" policy which means any person testing positive will be entitled for free treatment by the state and central government. It also provides for confidentiality of HIV-related information and makes it necessary to get informed consent for undertaking HIV tests, medical treatment and research.
The Indian pharmaceutical industry must consider the January 1, 2018 deadline issued by the Comptroller General of India Drugs (DCGI) as sacrosanct to improve the skills of people employed in their units, according to the Life Sciences Sector Skill Development Council (LSSSDC) set up under the auspices of the Ministry of Skills Development.
Small and medium-sized generic drug manufacturers in India say that the threat of stricter rules and higher barriers for foreigners in the US healthcare market will force a lot to find a niche or focus their expansion efforts on other countries.
The Ministry of Health is considering setting up an online portal to regulate and fill gaps in the sale of drugs in India across all platforms, including pharmacies. "The objective of such regulation would be to ensure the availability of drugs that meet quality standards to each person in need of medicines, to curb antimicrobial resistance and to regulate the supply of drugs online, "The ministry said.
Both Johnson & Johnson and Danish partner Bavarian Nordic have induced a lasting immune response for a full year in 100% of vaccinated healthy volunteers, researchers reported. The world should be much better prepared for the next Ebola epidemic, with other promising results showing the potential of a long-lived lethal virus vaccine.
The policy, which had been pending for more than two years, also suggests raising public health spending to 2.5% of GDP, compared with 1.2% currently. EU Health Minister J P Nadda is expected to make a statement on the policy in Parliament.
The NPPA drug price regulator has capped the prices of four essential drugs and revised 14 others, including those used for the treatment of fungal infections and hypertension.
Since its inception, the National Pharmaceutical Pricing Authority (NPPA) has published 1,527 notices of demand to companies for surcharges on sales of formulations at prices above the notified ceiling price. Drug price regulator NPPA received Rs 672.28 fine crore up to date from pharmaceutical companies for overcharge, Parliament was informed.
[adsense:336x280:8701650588]
The main brands of some of the drugs used for the treatment of heart disease and diabetes are up to 10 times higher than generic drugs, the government said.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
